Novel conjugation chemistry for catalytic anttibody 38c2
WO2021076755A1
An activity-guide map of electrophile-cysteine interactions in primary human immune cells
WO2021076559A1
Human broadly neutralizing antibodies against the membrane-proximal external region of hiv env for vaccine design and intervention
WO2021076563A1
Efficient rna switches and related expression systems
WO2021072167A1
Compositions and methods for in vivo synthesis of unnatural polypeptides
WO2021067313A1
Eukaryotic semi-synthetic organisms
US2020407402A1
Stabilized coronavirus spike (S) protein immunogens and related vaccines
WO2021050956A1
Antiviral prodrugs and pharmaceutical compositions thereof
WO2021035257A1
Monocyclic agonists of stimulator of interferon genes sting
WO2021035258A1
Bicyclic agonists of stimulator of interferon genes sting
WO2021021904A1
Pharmacological inhibitors of the enl yeats domain
WO2021021811A2
Myosin derived peptides and related compounds with anticoagulant activities
US2021024585A1
Engineered HCV E2 Immunogens and Related Vaccine Compositions
WO2020264572A1
Fragment-based screening to identify small molecules that selectively bind rna
WO2020264560A1
Target validation, binding site identification, and profiling of rna targets
WO2020257221A1
Methods and compositions for treating inflammatory conditions
WO2020252329A1
Immune checkpoint blocking bispecific molecules
WO2020252262A1
Reagents and methods for replication, transcription, and translation in semi-synthetic organisms
WO2020247510A1
A chemoenzymatic method for the detection of cell-cell proximity interaction and isolation of tumor-specific antigen reactive t cells for immune therapy
WO2020243754A1
LIGAND-ENABLED ß-C(sp3)–H LACTONIZATION FOR ß-C–H FUNCTIONALIZATIONS
